Document is current
Any future updates will be listed below
-
Authors
Thomas, Scott
Roche, Elysia
Desai, Pujan
Pawlowska, Nela
Bauer, Diana
Gingrich, David
Hsu, Emily
Deitchman, Amelia N.
Aweeka, Fran
Munster, Pamela N.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 CA220131)
National Institutes of Health (R01 CA220131)
National Institutes of Health (R01 CA220131)
National Institutes of Health (R01 CA220131)
National Institutes of Health (R01 CA220131)
Knauss Family
Evan Goldberg
- License Information
-
More Information
Article History
Received: 17 October 2023
Accepted: 21 October 2024
First Online: 24 January 2025
Change Date: 18 July 2025
Change Type: Update
Change Details: This article has been updated to amend the license information.
Declarations
:
: PNM, ST, PD, and NP are listed as inventors on UCSF patents pertaining to drug eluting implants for the treatment and prevention of cancer. PNM and ST are founders of Alessa Therapeutics, Inc, own stock, and remain paid consultants. Alessa Therapeutics develops drug eluting implants for the treatment of prostate cancer. PD contributed to this work while an employee of UCSF, and is now an employee of both UCSF and Alessa Therapeutics. All other authors have no competing interests.
: All animal procedures were approved by the UCSF Animal Care Use Committee.
